Breaking Barriers: Meeting Diversity Goals In Clinical Trials Through Innovative Smart Trial Design Strategies

Various stakeholders in clinical trials, including Regulatory Agencies, Contract Research Organizations (CROs), and Pharmaceutical and Biotech companies, have recognized the importance of enhancing the accessibility of clinical trials for underserved populations. In the United States, the DEPICT ACT mandates the establishment of Diversity Action Plans that specify enrollment targets based on race, ethnicity, age, and sex.

Initiating a well-informed trial design is a pivotal aspect of the solution. This includes determining which research sites can effectively recruit specific patient demographics, continuously monitoring actual enrollment rates for various subgroups and site-specific targets, implementing efficient data access and evaluation methods, and maximizing insights into predefined key metrics and indicators.

In this presentation, the following speakers explore how technology can assist in identifying and selecting the most suitable research sites and investigators for your therapeutic area:

• Elke Ydens, Associate Director of Business Solutions
• Laura Acosta, Vice President of Product Management for the eClinical Suite

In addition, the presenters also cover the challenges associated with collecting diversity-related data, how to streamline the process of site selection and diversity enhancement strategies, and establishing a robust plan for tracking and reporting on diversity goals.

Access the webinar below and begin delving into strategies for effectively monitoring and reporting progress toward achieving your patient diversity objectives.